NASDAQ · IPHA

Innate Pharma SA

Closing price · Nov 13, 2026 $1.38

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

10 funds report owning IPHA, up from 9

Holdings as of Jun 30, 2026
New3
Added2
Held3
Trimmed2
Sold out2

Insider trades · last 12 months

Real buys and sales

No insider filings loaded for the last 12 months.

Top holders

Biggest funds in IPHA

As of Jun 30, 2026
FundValueChange
Lion Point Capital, LP$149KSame
Morgan Stanley$80.1KSame
SmartHarvest Portfolios, LLC$43.7KNew
XTX Topco Ltd$27.8KNew
Citadel Advisors LLC$22.9KNew

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast